432 related articles for article (PubMed ID: 6163587)
21. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
Wigley FM
Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
[TBL] [Abstract][Full Text] [Related]
22. Scleroderma in children.
Cassidy JT; Sullivan DB; Dabich L; Petty RE
Arthritis Rheum; 1977 Mar; 20(2 Suppl):351-4. PubMed ID: 263912
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases.
Poirier TJ; Rankin GB
Am J Gastroenterol; 1972 Jul; 58(1):30-44. PubMed ID: 4537959
[No Abstract] [Full Text] [Related]
24. [Recent advances in Raynaud's syndrome].
Klein-Weigel P
Dtsch Med Wochenschr; 2012 Mar; 137(13):622-4. PubMed ID: 22434167
[No Abstract] [Full Text] [Related]
25. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
Curr Opin Rheumatol; 1997 Nov; 9(6):B199-206. PubMed ID: 9375289
[No Abstract] [Full Text] [Related]
26. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.
Surwit RS; Gilgor RS; Allen LM; Duvic M
Arch Dermatol; 1984 Mar; 120(3):329-31. PubMed ID: 6367665
[TBL] [Abstract][Full Text] [Related]
27. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
Kowal-Bielecka O; Landewé R; Avouac J; Chwiesko S; Miniati I; Czirjak L; Clements P; Denton C; Farge D; Fligelstone K; Földvari I; Furst DE; Müller-Ladner U; Seibold J; Silver RM; Takehara K; Toth BG; Tyndall A; Valentini G; van den Hoogen F; Wigley F; Zulian F; Matucci-Cerinic M;
Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
[TBL] [Abstract][Full Text] [Related]
28. [A case of systemic sclerosis in childhood complicated by severe digital ulcers].
Falcini F; Volpi M; Pierattelli M; Taccetti G; Pratesi G; Matucci Cerinich M
Pediatr Med Chir; 1984; 6(5):703-7. PubMed ID: 6535137
[TBL] [Abstract][Full Text] [Related]
29. [Raynaud's syndrome: diagnosis and therapy].
Mahler F
Ther Umsch; 1985 Oct; 42(10):671-7. PubMed ID: 3909486
[No Abstract] [Full Text] [Related]
30. Systemic sclerosis (scleroderma) and related disorders: clinical aspects.
Clements PJ
Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):1-16. PubMed ID: 10882211
[TBL] [Abstract][Full Text] [Related]
31. [Visceral manifestations of diffuse scleroderma].
Suţeanu S; Moise A; Stoicescu M
Med Interne; 1988; 26(2):125-38. PubMed ID: 3291079
[No Abstract] [Full Text] [Related]
32. [Use of plethysmography for the evaluation of peripheral blood vessels with particular reference to Raynaud's disease and conditions preceding scleroderma].
Stroińska W
Przegl Dermatol; 1967; 54(4):463-9. PubMed ID: 6052346
[No Abstract] [Full Text] [Related]
33. Raynaud's phenomenon and systemic sclerosis.
Generini S; Kahaleh B; Matucci-Cerinic M; Pignone A; Lombardi A; Ohtsuka T
Ann Ital Med Int; 1996; 11(2):125-31. PubMed ID: 8974438
[TBL] [Abstract][Full Text] [Related]
34. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
[TBL] [Abstract][Full Text] [Related]
35. Limited cutaneous systemic sclerosis: report of one case.
Lin MC; Fu LS; Huang KY; Tsen CF; Liou JM; Chi CS
Acta Paediatr Taiwan; 2001; 42(4):248-51. PubMed ID: 11550416
[TBL] [Abstract][Full Text] [Related]
36. [Capillaroscopic evaluation of the effects of nifedipine in patients with Raynaud's phenomenon].
Riccio A; Pennarola R; Farinaro C; Scherillo G; Infranzi E; Del Puente A; Oriente P
Clin Ter; 1988 May; 125(3):185-90. PubMed ID: 2973939
[No Abstract] [Full Text] [Related]
37. Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud's phenomenon in patients with systemic sclerosis.
Sulli A; Seriolo B; Savarino V; Cutolo M
J Rheumatol; 2000 Jul; 27(7):1820-1. PubMed ID: 10914880
[No Abstract] [Full Text] [Related]
38. Systemic connective tissue diseases in India, VI. Raynaud's disease and pre-progressive systemic sclerosis (Pre-PSS).
Malaviya AN; Narayanan K; Tiwari SC; Khan KM; Raina V; Pande JN
J Assoc Physicians India; 1983 Oct; 31(10):625-8. PubMed ID: 6671930
[No Abstract] [Full Text] [Related]
39. Current options for the treatment of systemic scleroderma.
McGee BA; Barnett MD; Small RE
Clin Pharm; 1991 Jan; 10(1):14-25. PubMed ID: 1999084
[TBL] [Abstract][Full Text] [Related]
40. Clinical features, pathogenic mechanisms, and new developments in the treatment of systemic sclerosis.
Geppert T
Am J Med Sci; 1990 Mar; 299(3):193-209. PubMed ID: 2180298
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
